Objective: To evaluate the effect of Shentekang Capsule (STKC) combined with peritonealdialysis (PD) in treating chronic renal failure (CRF). Methods: With single-blind, parallel control and random method, 60 cases of...Objective: To evaluate the effect of Shentekang Capsule (STKC) combined with peritonealdialysis (PD) in treating chronic renal failure (CRF). Methods: With single-blind, parallel control and random method, 60 cases of CRF patients were equally divided into 2 groups: (1 ) STKC group treated with combined therapy of STKC and PD; (2 ) control group treated with PD alone. The course of treatment were 1~ 2 months for both groups. Clinical manifestations, blood urea nitrogen, serum creatinine, total protein and hemoglobin were observed before and after the treatment. Results: Blood urea nitrogen decreased in both groups after treat ment as compared with that before treatment significantly (P< 0. 05), but no obvious difference was found be tween blood urea nitrogen levels of the two groups (P > 0. 05 ). However, levels of serum total protein and hemoglobin of the STKC group after treatment were higher than those of the control group (P < 0. 01 ). Clinical manifestation in STKC group also showed more improvement after treatment than that in the control group.Conclusion: STKC could improve nutritional state and quality of CRF patient's life treated with PD.展开更多
文摘Objective: To evaluate the effect of Shentekang Capsule (STKC) combined with peritonealdialysis (PD) in treating chronic renal failure (CRF). Methods: With single-blind, parallel control and random method, 60 cases of CRF patients were equally divided into 2 groups: (1 ) STKC group treated with combined therapy of STKC and PD; (2 ) control group treated with PD alone. The course of treatment were 1~ 2 months for both groups. Clinical manifestations, blood urea nitrogen, serum creatinine, total protein and hemoglobin were observed before and after the treatment. Results: Blood urea nitrogen decreased in both groups after treat ment as compared with that before treatment significantly (P< 0. 05), but no obvious difference was found be tween blood urea nitrogen levels of the two groups (P > 0. 05 ). However, levels of serum total protein and hemoglobin of the STKC group after treatment were higher than those of the control group (P < 0. 01 ). Clinical manifestation in STKC group also showed more improvement after treatment than that in the control group.Conclusion: STKC could improve nutritional state and quality of CRF patient's life treated with PD.
